我现在一个中大型药厂，公司在上升阶段，发展很快。我在drug development group干了快10年了。工作比较稳定，管一个将近10人的小组。往上升职的可能性比较小。有些厌倦了。想换到regulatory affairs去。好处是将来跳到别的公司比较容易。另外，可以基本上work from home，没有lab work了. 不好的地方是要从头学起。压力可能大些。本人快奔5了，是该躺平还是再挑战一下自己，学点新东西。比较犹豫，想听听建议。
For OP, you are currently an AD in technical function with 10 direct reports, you have decent opportunities to be promoted to director. You just need to be patient. If your technical function is CMC, you have good pathway to join Reg-CMC, however, it depends on your experiences and how many filings you have participated. In addition, promotion in Reg-CMC function is very very slow. People did not get this in this thread. Reg-CMC is a very demanding job, almost 24/7, your quality of life will be impacted if you want this type of job. However, it gives you good job security, and you do have a good chance to switch to another company Reg-CMC and get promoted. If your technical function is CMC, you have almost NO pathway to join Reg Affairs, since it is quite different. Another career path is to become matrix team leader, like CMC team lead, DP team lead. These requires you be a good strategic thinker and developer. If you have never done strategy works as your primary job before, it will take some time to adapt. But this is a good career path as well.
This is a different type of "累" for reviewers vs leaders in big pharma Reviewer has deadlines, because PDUFA date, you have to complete your review on time. However, reviewing is an operation job, there is not too many big decisions to make during your review, and you don't have to worry about the quality of your questions. And, most importantly, you can just write your review questions and your work is done. For people from big pharma, "累" means big decisions to make, significant accountability and challenge to align people on strategy. There could have significant consequences if you have made the wrong decision, like a filing was rejected and you may lose your job. You have to spend countless hours to discuss and align strategy before getting anything done. And if you can not reach agreement, maybe nothing will be done and you will be labeled as a weak leader cannot get things achieved
big pharma AD is also depending on the department and degreee, normally MD>PhD >Pharma D, AD for clinical development is normally 130-180 base, 15-20% target bonus plus stock (some pharma only offer D or higher level stock). SF and boston will pay higher.
big pharma AD is also depending on the department and degreee, normally MD>PhD >Pharma D, AD for clinical development is normally 130-180 base, 15-20% target bonus plus stock (some pharma only offer D or higher level stock). SF and boston will pay higher. babytinny小猪 发表于 2022-11-11 10:43
big pharma AD is also depending on the department and degreee, normally MD>PhD >Pharma D, AD for clinical development is normally 130-180 base, 15-20% target bonus plus stock (some pharma only offer D or higher level stock). SF and boston will pay higher. babytinny小猪 发表于 2022-11-11 10:43
想去就去，试试无妨，人就活一辈子，不要考虑太多。
公司现在已经算是大公司了，所以升D的可能性越来越小了。工资倒是一直涨，就是觉得有些到头的感觉。现在的部门是supporting role。出力不讨好。手下人在这hybrid情况下也越来越难管了。心累。
工资不会受影响。职位不知道。这里有在regulatory affair的吗？中国人适合吗？对语言的要求高不高？
管10个人还不是D真是有点鸡肋,同意上面的一位意见，转translational science 至VP封顶，当然regulator affair 也不错，职位上升快, 有内部转的机会不要错过，但是语言能力要过关。
为啥管这么大group还有lab work？我只管几个人就可以WFH没有lab work了
我没有lab work，但是因为手下人要去lab,做manager的也只能以身作则了。
我转CMC肯定是更容易些。regulatory affair和 regulatory CMC哪个职业前景更好，更适合中国人。我语言在国人里算中等偏上，但肯定比不了native speaker.
是呀，管10个人，但是title没跟上，所以干的也挺没劲的。
那建议转regulatory CMC, 虽然visibility 差一点，但是也更轻松也符合你的scientific background. 另外，在Regulatory不管人都可以轻松升级到D.
Medical affairs 当然要去大厂，各种资源丰富，否则那些有名的医生和下面的临床助理可能都不愿理你。
干啥？去的都是做reviewer，很累
reviewer就挺好的啊。那药厂为什么就清闲了？
是reviewer 比药厂清闲。压力小。旱涝保收。但是工资会缩水。FDA不会三天两头裁人。也不会match 工资。你爱来不来吧。反正药厂裁下来的人一波接一波。
sorry问题比较初级，没有去过药厂， 在consider 一个position。谢谢！
FDA reviewer is typically GS13 and GS14, and is paid about 100K less than a big pharma associate director
this is BS, there are so many H1B in big pharma that are AD and above
reviewer 据说都是13万多，你算的还挺靠谱的。
不干reviewer 也不能算跟公司AD一个级别就是了。
你说的这个对，相对钱少是真的，但是那个人说reviewer累，我就不能理解了。。。。 不过director和reviewer比也不对，去了FDA也做director那工资就比reviewer高啦。
都是reviewer跟我说累的，不值得的，含我现在公司同事。好几个medical reviewer都说比公司累多了，压力大多了。虽然公司压力也大。
这个每个人样本不一样，不信就算了。
This is a different type of "累" for reviewers vs leaders in big pharma Reviewer has deadlines, because PDUFA date, you have to complete your review on time. However, reviewing is an operation job, there is not too many big decisions to make during your review, and you don't have to worry about the quality of your questions. And, most importantly, you can just write your review questions and your work is done. For people from big pharma, "累" means big decisions to make, significant accountability and challenge to align people on strategy. There could have significant consequences if you have made the wrong decision, like a filing was rejected and you may lose your job. You have to spend countless hours to discuss and align strategy before getting anything done. And if you can not reach agreement, maybe nothing will be done and you will be labeled as a weak leader cannot get things achieved
感觉这个对非母语的还是有点难，communication要求高一点，脑子也要很清楚，机会很多但是入行比较难吧
分人吧我觉得有的人就特别适合做这个
真的管10个人还不是D 那楼主的title是什么
如果D都不到没用吧，除非包裹大，楼主很喜欢管人么
这个忙吗？之后去药企很容易吧
想转regulatory 的话，经验非常重要，如果以前没有相关经验的话，要从入门级别做起，偏operation, 这些人大多数是刚毕业两三年的PharmD, 也有PhD, 不拖家带口，一周6，70 小时都可以，主要就是攒经验，可塑性强的advanced的快。从其他部门转，最开始几年要有放低身价的准备，后面的发展要看机遇看人。
是这样的，现在都是PharmD+MPH甚至外加1-2年药厂fellow，然后senior manager干起，几年就是AD/D了
估计是AD，在药企package在200k到300k
sr. director package一般多少？
AdAD能到30w这么多么 而且股票三年兑现的话 还不知道能不能扛三年 跳槽就没了
big pharma AD is also depending on the department and degreee, normally MD>PhD >Pharma D, AD for clinical development is normally 130-180 base, 15-20% target bonus plus stock (some pharma only offer D or higher level stock). SF and boston will pay higher.
这个工资看着比较靠谱。药厂工资20万以上也挺难的吧。
我们招phd entry level range是11-13万base, 不是clinical development但也是R&D，今年招了两个人都给了range里最高，其中一位因为我们特别喜欢还在13万上加了钱
没啥难的，base 20以上是要d level。ad package应该轻松上20，s. manager很多package也是20以上，但药厂的人没人拿package出来说，各个公司range很大，特别大小Pharma差距很大
Ad package 还真不是轻松上20的吧。。。
和我知道的一样
seriously？昨天还在一亩三分地看到一个fresh phd报intern 的return offer, 二十万，湾区的药厂。AD估计至少三十万以上
package不到20的ad可以果断跳槽了
可能股票比较多，base不太可能这么高
跟regulator打交道的经验也值钱吧，jd上动不动要求做过submission，可是做个成功的药那么难，哪那么容易有submission经验啊。
药厂senior manager title 这么廉价吗？看工资感觉对不起那个title 啊……
现在主流药厂里面manager 是个边缘化的职位
正经ladder上，第一级管人的是AD， 然后是D，SD, manager 反而往往是给不管人的人的title，比如管理实验室的，还有像regulatory这种不管人，但是要给上title来给相应工资的
药厂title很混乱的，某大厂临床senior manager就是phd加1-2年经验，主要是临床这块工资给的高，不能和临床前R&D同一个title。 现在title也通胀了，AD在很多药厂也只能是IC，要管人最少是D。但AD的base也涨到18-22w。